TYK2 inhibitors and compositions and methods thereof

CN121843931APending Publication Date: 2026-04-10LYNK PHARMACEUTICALS CO LTD
10 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-14
Publication Date
2026-04-10
Patent Text Reader

Abstract

The invention provides a novel class of therapeutic agents, which are safe and effective TYK2 inhibitors, and also provides pharmaceutical compositions of these compounds, methods of preparing the same, and uses thereof in allusion to various TYK2-mediated diseases and disorders.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Compounds having TYK2 inhibitory activity, pharmaceutical compositions containing same, and uses thereof

    CN115466257A

  • Nitrogen-containing aryl derivative regulator, preparation method and application thereof

    CN116262739A

  • Ophthalmological composition of the type which undergoes liquid-gel phase transition

    US4861760A

  • Sustained release, comfort formulation for glaucoma therapy

    US4911920A

  • Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions

    US5212162A